Hill staff gets briefed on implications of Trump’s drug pricing plan

Taking stock of the drug industry, from the lab to the medicine chest

September 22, 2025 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Nardus Engelbrecht/AP STAT+ | CDC recommends new Gilead HIV prevention drug, prompting advocates to push CVS for coverage CVS Health, which runs the largest pharmacy benefits manager in the U.S., is so far not covering the Gilead drug. By Ed Silverman STAT+ | Federal vaccine panel remade by RFK Jr. votes to maintain insurance coverage for Covid shots The panel's decision would preserve broad insurance coverage for Covid-19 shots, even though some panelists questioned their benefits and safety. By Lizzy Lawrence and Chelsea Cirruzzo Key federal vaccine panel tables vote on delaying newborn hepatitis B shot In a closely watched vote, ACIP members decided to maintain the status quo for now on whether to delay when infants get the shot. By Anil Oza Alex Hogan/STAT STAT+ | Up and down the ladder: The latest comings and goings From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry. By Ed Silverman

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser